Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.

Journal Article (Journal Article)

The RV144 vaccine trial in Thailand demonstrated that an HIV vaccine could prevent infection in humans and highlights the importance of understanding protective immunity against HIV. We used a nonhuman primate model to define immune and genetic mechanisms of protection against mucosal infection by the simian immunodeficiency virus (SIV). A plasmid DNA prime/recombinant adenovirus serotype 5 (rAd5) boost vaccine regimen was evaluated for its ability to protect monkeys from infection by SIVmac251 or SIVsmE660 isolates after repeat intrarectal challenges. Although this prime-boost vaccine regimen failed to protect against SIVmac251 infection, 50% of vaccinated monkeys were protected from infection with SIVsmE660. Among SIVsmE660-infected animals, there was about a one-log reduction in peak plasma virus RNA in monkeys expressing the major histocompatibility complex class I allele Mamu-A*01, implicating cytotoxic T lymphocytes in the control of SIV replication once infection is established. Among Mamu-A*01-negative monkeys challenged with SIVsmE660, no CD8(+) T cell response or innate immune response was associated with protection against virus acquisition. However, low levels of neutralizing antibodies and an envelope-specific CD4(+) T cell response were associated with vaccine protection in these monkeys. Moreover, monkeys that expressed two TRIM5 alleles that restrict SIV replication were more likely to be protected from infection than monkeys that expressed at least one permissive TRIM5 allele. This study begins to elucidate the mechanisms of vaccine protection against immunodeficiency viruses and highlights the need to analyze these immune and genetic correlates of protection in future trials of HIV vaccine strategies.

Full Text

Duke Authors

Cited Authors

  • Letvin, NL; Rao, SS; Montefiori, DC; Seaman, MS; Sun, Y; Lim, S-Y; Yeh, WW; Asmal, M; Gelman, RS; Shen, L; Whitney, JB; Seoighe, C; Lacerda, M; Keating, S; Norris, PJ; Hudgens, MG; Gilbert, PB; Buzby, AP; Mach, LV; Zhang, J; Balachandran, H; Shaw, GM; Schmidt, SD; Todd, J-P; Dodson, A; Mascola, JR; Nabel, GJ

Published Date

  • May 4, 2011

Published In

Volume / Issue

  • 3 / 81

Start / End Page

  • 81ra36 -

PubMed ID

  • 21543722

Pubmed Central ID

  • PMC3718279

Electronic International Standard Serial Number (EISSN)

  • 1946-6242

Digital Object Identifier (DOI)

  • 10.1126/scitranslmed.3002351


  • eng

Conference Location

  • United States